パーキンソン病におけるヘクソシルセラミドの上昇は,病原体に対する反応を模倣するニューロンの遺伝子上調を引き起こす
Luisa Franck1, Lisa Hahnefeld1,2, Lucie Valek1
1Goethe University Frankfurt, Faculty of Medicine, Institute of Clinical Pharmacology, Frankfurt am Main, Germany.
NPJ Parkinson's disease
|August 30, 2025
まとめ
パーキンソン病 (PD) のモデルにおけるグルコシルセラミド (GlcCer) の上昇は,脂質代謝の障害を示唆する. この蓄積,特に GlcCer24: 1は,感覚ニューロンの先天的な免疫反応を活性化し,PD病理に寄与します.
科学分野:
- 神経科学
- 生物化学
- 免疫学
背景:
- パーキンソン病 (PD) の病原化には,α-シヌクレイン (αSyn) の結合が含まれています.
- 酸性グルコセレブロシダース (GCase) 機能障害に関連した,グリコスフィンゴリピド代謝の障害は,αSynの形成を促進する.
- グルコシルセラミド (GlcCer) はPDに関与しているが,その正確な役割と蓄積パターンはさらなる調査を必要としている.
研究 の 目的:
- パーキンソン病 (PD) の様々なモデルにおけるグルコシルセラミド (GlcCer) の蓄積と影響を調査する.
- GlcCerレベル,αSyn病理,およびPDにおける神経応答の関係を探求する.
主な方法:
- PD患者とマウスモデルの血と脳組織の脂質解析
- αSyn繊維に曝された患者由来フィブロブラストとニューロン細胞系を用いた細胞研究.
- GlcCerに反応する遺伝子発現の変化を分析するためのRNA配列解析 (RNAseq).
主要な成果:
- 血のGlCer,特にGlCer24:1,および変異したフォスファディチルコリン (PC) 種がPD患者で観察されました.
- GlcCerと硫化物 (SHexCer) の増加はPDマウス脳で発見され,αSyn線維に曝露したニューロンにGlcCerが蓄積された.
- GlcCer24: 1は,αSyn繊維の毒性を悪化させ,病原体に関連するシグナル伝達に似ている感覚神経細胞におけるグリコリピド応答遺伝子を誘発した.
結論:
- 細胞外GluCerはパーキンソン病で上昇する.
- 蓄積されたGlcCerは感覚神経細胞に先天的な免疫反応を引き起こし,PDの進行に潜在的に貢献します.
- GlcCerの代謝はPDの潜在的な治療目標です.
さらに関連する動画
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.1K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.6K
関連する概念動画
Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
